Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

NCT00861705 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

454

Enrollment

NIH

Sponsor class

Conditions

Male Breast Carcinoma
Stage IIA Breast Cancer AJCC v6 and v7
Stage IIB Breast Cancer AJCC v6 and v7
Stage IIIA Breast Cancer AJCC v7
Triple-Negative Breast Carcinoma

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Carboplatin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel

Sponsor

National Cancer Institute (NCI)